# Xsphera Biosciences Inc — Form D

Xsphera Biosciences Inc of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-04. The offering totals $19.9M, of which $12.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-05-04
- Form: D
- Accession: 0001934197-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $19.9M
- Amount sold: $12.6M
- Remaining: $7.3M
- Investors: 40
- Date of first sale: 2023-04-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480877

## Issuer

- Name: Xsphera Biosciences Inc
- CIK: 0001934197
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 6 TIDE STREET, BOSTON, MA, 02110
- Phone: 6178323030

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Stephen Remondi | Director | Boston, MA |
| Robert Walsh | Director | Bedford, TX |
| Stephen Remondi | Executive Officer | Boston, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-06-16](https://search.stillhousedata.com/formd/0001934197-22-000001) | D | $3.0M | $100K |

## More

- [CIK 1934197 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1934197&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001934197-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.